Loading...
Back to narrative

Update shared on08 Oct 2025

Fair value Increased 2.84%
AnalystConsensusTarget's Fair Value
US$24.13
7.7% undervalued intrinsic discount
08 Oct
US$22.28
Loading
1Y
-53.0%
7D
-13.5%

Olin's fair value estimate has increased modestly from $23.47 to $24.13 per share, as analysts revise expectations following lowered growth outlooks. They also note stabilization in key markets and the prospect of improving commercial sales performance.

Analyst Commentary

Recent research updates reflect a balanced view of Olin’s future outlook, with both optimism regarding stabilization and persisting concerns on growth execution.

Bullish Takeaways

  • Bullish analysts see increasing signs of EBITDA stabilization in key market segments and indicate that the bottom may have been reached.
  • Improving performance in commercial sales is expected, particularly as management highlights a likely upturn in Winchester sales declines.
  • Key operational segments such as chlor-alkali and epoxy are considered unlikely to deteriorate further. This supports a more stable valuation baseline.
  • Ongoing adjustments in commercial strategy could position Olin for better margin preservation and recovery in future quarters.

Bearish Takeaways

  • Bearish analysts have downgraded expectations and reflect cooling sentiment on near-term growth and execution risks.
  • Recent valuation target reductions are tied to 2025 EBITDA projections coming in below earlier estimates, especially in base epoxy resins and the Winchester commercial segment.
  • There remains uncertainty around the company’s ability to boost commercial pricing. This is viewed as essential for margin defense heading into next year.
  • Persisting challenges in select business lines continue to weigh on overall confidence and limit confidence in a quick rebound for the stock.

What's in the News

  • Olin Corporation is transitioning its participation in the vinyls value chain by ending its Blue Water Alliance joint venture with Mitsui by year-end. Both parties will continue to collaborate under a more flexible framework, ensuring continuity for BWA customers (Key Developments).
  • The board of directors has amended Olin's Bylaws to change procedures for shareholder director nominations and proposals. Director candidates are now required to be available for board interviews and other procedural points have been clarified (Key Developments).
  • Between April 1, 2025 and June 30, 2025, Olin repurchased 510,088 shares for $10.01 million, progressing its ongoing buyback program announced in July 2022 (Key Developments).

Valuation Changes

  • Fair Value Estimate: Increased slightly to $24.13 per share from $23.47 per share, reflecting updated analyst models.
  • Discount Rate: Reduced marginally from 9.61% to 9.59%, indicating modestly improved risk assumptions.
  • Revenue Growth: Lowered from 3.58% to 2.84% as expectations for topline expansion have moderated.
  • Net Profit Margin: Declined to 4.89% from 5.07%, suggesting slightly weaker profitability projections.
  • Future P/E: Increased to 9.68x from 8.89x, indicating a shift to a higher expected valuation multiple.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.